Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Learn which indices traders watch most closely and why. This quick primer covers the benchmarks that shape trading strategies and risk assessment.
26,463 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Cerebras exploded higher on its debut, but what comes next for investors? This guide breaks down the hype, the fundam...
Analysts weigh a path to $400 per share by 2028 as Apple rides iPhone demand and Services expansion, even as market h...
The market buzz around Sweetgreen stock is loud, but hype isn’t a plan. This article weighs momentum against business...
Structure Therapeutics stock has surged after a major hedge fund increased its stake. This article breaks down what s...
Applied Optoelectronics shares climbed after a strong quarterly showing and renewed appetite for laser transceivers f...
Nvidia is a cornerstone of the AI era, and its upcoming earnings can move markets. This guide breaks down what to con...
SpaceX's IPO debut has turned into a high-velocity, meme-like run as investors chase a limited float. Crypto-linked f...
Bitcoin’s Q2 move coincided with a rare drop in stablecoins, underscoring a broader liquidity squeeze as BTC fell and...
Krispy Kreme’s stock jumped after a quarterly report showed potential signs of a turnaround, even as revenue declined...
Microvast’s Q4 2025 results trigger a sharp pullback in mvst stock down this year. A $32.5 million inventory impairme...
IBM led a narrow rally in a mixed tech session, jumping 8% while Oracle, Cisco, and HPE drifted. The move raises ques...